Should Moderna Before Aug.: A Clear Investor Guide for 2026
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesAs Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
Arm Holdings has ridden a scorching AI-fueled rally in 2026, but today’s roughly 10% slide raises questions about mom...
Palantir’s AI-enabled analytics engine has fueled growth, but the stock faces multiple headwinds. This article lays o...
In a volatile 2026 market, a defensively positioned dividend stock offers stock ultimate dividend safety. Coca-Cola i...
A leading hedge fund poured nearly $40 million into GRAIL last quarter, only to see the stock tumble. This article un...
Ecopetrol sits at the crossroads of a volatile energy market and a growing emerging markets economy. This deep dive b...
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...
As Neogen gears up for Q3 2026 earnings, investors are digging for signals beyond the headline numbers. This article ...
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
When a company director buys a sizable stake, investors take notice. This article breaks down the meaning behind the ...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...